Halozyme Therapeutics | HALO - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Baxter International USD 8.67B 1.15B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Cytokinetics USD 8.19B 420M 2026-03
DBV Technologies USD 274M 17M 2025-09
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.66B 257M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
MannKind USD 757M 984M 2026-03
Nektar Therapeutics USD 11.91B 11.05B 2026-06
Pfizer USD 153.81B 12.24B 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12